These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

951 related items for PubMed ID: 19744717

  • 1. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB, House J, Hong KC, Lakew T, Alemayehu W, Zhou Z, Moncada J, Rogér A, Keenan J, Gaynor BD, Schachter J, Lietman TM.
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [Abstract] [Full Text] [Related]

  • 2. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK, Munoz B, Mkocha H, Gaydos C, Quinn T.
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [Abstract] [Full Text] [Related]

  • 3. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
    Yang JL, Hong KC, Schachter J, Moncada J, Lekew T, House JI, Zhou Z, Neuwelt MD, Rutar T, Halfpenny C, Shah N, Whitcher JP, Lietman TM.
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
    [Abstract] [Full Text] [Related]

  • 4. Complete elimination is a difficult goal for trachoma programs in severely affected communities.
    Gill DA, Lakew T, Alemayehu W, Melese M, Zhou Z, House JI, Hong KC, Ray KJ, Gandhi N, Whitcher JP, Gaynor BD, Lietman TM.
    Clin Infect Dis; 2008 Feb 15; 46(4):564-6. PubMed ID: 18194094
    [Abstract] [Full Text] [Related]

  • 5. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.
    Melese M, Alemayehu W, Lakew T, Yi E, House J, Chidambaram JD, Zhou Z, Cevallos V, Ray K, Hong KC, Porco TC, Phan I, Zaidi A, Gaynor BD, Whitcher JP, Lietman TM.
    JAMA; 2008 Feb 20; 299(7):778-84. PubMed ID: 18285589
    [Abstract] [Full Text] [Related]

  • 6. A rationale for continuing mass antibiotic distributions for trachoma.
    Ray KJ, Porco TC, Hong KC, Lee DC, Alemayehu W, Melese M, Lakew T, Yi E, House J, Chidambaram JD, Whitcher JP, Gaynor BD, Lietman TM.
    BMC Infect Dis; 2007 Aug 07; 7():91. PubMed ID: 17683646
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania.
    Broman AT, Shum K, Munoz B, Duncan DD, West SK.
    Invest Ophthalmol Vis Sci; 2006 Jan 07; 47(1):99-104. PubMed ID: 16384950
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas?
    Bird M, Dawson CR, Schachter JS, Miao Y, Shama A, Osman A, Bassem A, Lietman TM.
    J Infect Dis; 2003 May 15; 187(10):1669-73. PubMed ID: 12721948
    [Abstract] [Full Text] [Related]

  • 11. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
    Chidambaram JD, Alemayehu W, Melese M, Lakew T, Yi E, House J, Cevallos V, Zhou Z, Maxey K, Lee DC, Shapiro BL, Srinivasan M, Porco T, Whitcher JP, Gaynor BD, Lietman TM.
    JAMA; 2006 Mar 08; 295(10):1142-6. PubMed ID: 16522834
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for ocular chlamydia after three mass azithromycin distributions.
    Ayele B, Gebre T, Moncada J, House JI, Stoller NE, Zhou Z, Porco TC, Gaynor BD, Emerson PM, Schachter J, Keenan JD.
    PLoS Negl Trop Dis; 2011 Dec 08; 5(12):e1441. PubMed ID: 22180804
    [Abstract] [Full Text] [Related]

  • 13. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
    Stare D, Harding-Esch E, Munoz B, Bailey R, Mabey D, Holland M, Gaydos C, West S.
    Ophthalmic Epidemiol; 2011 Feb 08; 18(1):20-9. PubMed ID: 21275593
    [Abstract] [Full Text] [Related]

  • 14. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.
    Melese M, Chidambaram JD, Alemayehu W, Lee DC, Yi EH, Cevallos V, Zhou Z, Donnellan C, Saidel M, Whitcher JP, Gaynor BD, Lietman TM.
    JAMA; 2004 Aug 11; 292(6):721-5. PubMed ID: 15304470
    [Abstract] [Full Text] [Related]

  • 15. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
    Morberg DP, Alemayehu W, Melese M, Lakew T, Sisay A, Zhou Z, Cevallos V, Oldenburg CE, Porco TC, Lietman TM, Keenan JD.
    Ophthalmic Epidemiol; 2019 Feb 11; 26(1):19-26. PubMed ID: 30153085
    [Abstract] [Full Text] [Related]

  • 16. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
    Keenan JD, Ayele B, Gebre T, Moncada J, Stoller NE, Zhou Z, Porco TC, McCulloch CE, Gaynor BD, Emerson PM, Schachter J, Lietman TM.
    Clin Infect Dis; 2012 Jan 15; 54(2):253-6. PubMed ID: 22095569
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.
    Fraser-Hurt N, Bailey RL, Cousens S, Mabey D, Faal H, Mabey DC.
    Bull World Health Organ; 2001 Jan 15; 79(7):632-40. PubMed ID: 11477966
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions.
    Keenan JD, See CW, Moncada J, Ayele B, Gebre T, Stoller NE, McCulloch CE, Porco TC, Gaynor BD, Emerson PM, Schachter J, Lietman TM.
    Invest Ophthalmol Vis Sci; 2012 Jan 25; 53(1):235-40. PubMed ID: 22159017
    [Abstract] [Full Text] [Related]

  • 19. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD, Tadesse Z, Gebresillasie S, Shiferaw A, Zerihun M, Emerson PM, Callahan K, Cotter SY, Stoller NE, Porco TC, Oldenburg CE, Lietman TM.
    PLoS Med; 2018 Aug 25; 15(8):e1002633. PubMed ID: 30106956
    [Abstract] [Full Text] [Related]

  • 20. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania.
    Wolle MA, Muñoz BE, Mkocha H, West SK.
    Ophthalmology; 2009 Feb 25; 116(2):243-7. PubMed ID: 19091415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.